Valuation Edwards Lifesciences Corporation

Stocks

Real-time Estimate Cboe BZX 01:21:49 22/10/2026 am IST			5-day change	1st Jan Change
88.20 ^USD	-0.10%		+1.91%	+3.34%

10:22pm	Edwards Lifesciences Corporation Receives FDA Approval For PASCAL Precision System For Tricuspid Valve Repair And PASCAL Ace With Capture Clarity System For Degenerative Mitral TEER Procedures	CI
07:45pm	Edwards Lifesciences Gets Approval for Tricuspid Valve Repair System From US FDA	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,883	46,128	46,246	43,663	49,471	50,890	-	-
Change	-	-42.97%	0.25%	-5.58%	13.3%	2.87%	-	-
Enterprise Value (EV) ¹	80,616	45,956	45,198	40,285	45,843	47,259	45,696	43,880
Change	-	-42.99%	-1.65%	-10.87%	13.8%	3.09%	-3.31%	-3.97%
P/E	54.4x	30.6x	33.2x	10.6x	46.6x	35.5x	26.6x	23.7x
PBR	13.9x	7.82x	6.99x	4.36x	4.79x	4.8x	4.17x	3.87x
PEG	-	12.14x	-5.79x	0x	-0.6x	1x	0.8x	1.9x
Capitalization / Revenue	15.5x	8.57x	7.7x	8.03x	8.15x	7.53x	6.85x	6.22x
EV / Revenue	15.4x	8.54x	7.53x	7.41x	7.56x	6.99x	6.15x	5.36x
EV / EBITDA	46.6x	23.7x	24.1x	24.1x	25.5x	22.2x	19.2x	16.4x
EV / EBIT	50.6x	25.6x	26.1x	26.6x	27.9x	24x	20.7x	17.7x
EV / FCF	57.3x	47.2x	47.9x	139x	34.3x	55.7x	28.4x	24.1x
FCF Yield	1.74%	2.12%	2.09%	0.72%	2.91%	1.8%	3.52%	4.14%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	2.38	2.44	2.3	6.97	1.83	2.486	3.322	3.733
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	5,232	5,382	6,005	5,440	6,068	6,762	7,434	8,185
EBITDA ¹	1,729	1,936	1,879	1,670	1,800	2,131	2,378	2,680
EBIT ¹	1,594	1,796	1,734	1,514	1,644	1,970	2,212	2,481
Net income ¹	1,503	1,522	1,402	4,175	1,074	1,435	1,898	2,040
Net Debt ¹	-267	-172.7	-1,048	-3,378	-3,628	-3,631	-5,195	-7,011
Reference price ²	129.55	74.61	76.25	74.03	85.25	88.29	88.29	88.29
Nbr of stocks (in thousands)	6,24,334	6,18,260	6,06,500	5,89,800	5,80,300	5,76,400	-	-
Announcement Date	26/01/22	31/01/23	06/02/24	11/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
EDWARDS LIFESCIENCES CORPORATION	35.51x	6.99x	22.18x	-.--%	5.09TCr
THERMO FISHER SCIENTIFIC, INC.	34.14x	5.97x	22.85x	0.27%	25TCr
DANAHER CORPORATION	38.16x	6.76x	21.41x	0.64%	16TCr
INTUITIVE SURGICAL, INC.	46.54x	12.6x	27.78x	-.--%	15TCr
BOSTON SCIENTIFIC CORPORATION	17.13x	3.42x	11.17x	-.--%	6.61TCr
VEEVA SYSTEMS INC.	48.79x	12.07x	26.6x	-.--%	5.16TCr
SIEMENS HEALTHINEERS AG	20.29x	2.44x	12.32x	2.49%	5.18TCr
AGILENT TECHNOLOGIES, INC.	33.71x	6.67x	22.63x	0.59%	4.88TCr
WATERS CORPORATION	77.52x	7.39x	22.48x	-.--%	4.35TCr
ILLUMINA, INC.	54.16x	8.74x	31.08x	-.--%	4.05TCr
Average	40.60x	7.31x	22.05x	0.4%	9.2TCr
Weighted average by Cap.	38.72x	7.46x	22.51x	0.36%